Foresight Group Ltd Liability Partnership Invests $13.56 Million in Silicon Laboratories, Inc. $SLAB

Key Points

• Foresight Group Ltd Liability Partnership has invested approximately $13.56 million in Silicon Laboratories by acquiring 120,461 shares in the first quarter, now making it the firm's 21st largest holding.
• Various institutional investors have shown increased interest in Silicon Laboratories, with several, including Quarry LP and UMB Bank, making new stakes in the first quarter.
• Analysts have generally positive ratings on Silicon Laboratories, with a current average rating of "Moderate Buy" and a target price of approximately $151.13 per share.

Foresight Group Ltd Liability Partnership bought a new stake in shares of Silicon Laboratories, Inc. (NASDAQ:SLAB - Free Report) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 120,461 shares of the semiconductor company's stock, valued at approximately $13,560,000. Silicon Laboratories comprises 2.0% of Foresight Group Ltd Liability Partnership's investment portfolio, making the stock its 21st largest holding. Foresight Group Ltd Liability Partnership owned about 0.37% of Silicon Laboratories as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the stock. Quarry LP acquired a new stake in Silicon Laboratories during the 1st quarter worth about $25,000. Skandinaviska Enskilda Banken AB publ purchased a new position in shares of Silicon Laboratories in the first quarter worth approximately $34,000. UMB Bank n.a. raised its holdings in shares of Silicon Laboratories by 111.3% during the first quarter. UMB Bank n.a. now owns 336 shares of the semiconductor company's stock valued at $38,000 after acquiring an additional 177 shares during the period. Parallel Advisors LLC lifted its position in shares of Silicon Laboratories by 143.7% in the 1st quarter. Parallel Advisors LLC now owns 463 shares of the semiconductor company's stock valued at $52,000 after acquiring an additional 273 shares in the last quarter. Finally, Larson Financial Group LLC acquired a new position in Silicon Laboratories in the 1st quarter worth approximately $55,000.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the company. Wall Street Zen upgraded Silicon Laboratories from a "sell" rating to a "hold" rating in a report on Wednesday, May 14th. Barclays upped their price target on Silicon Laboratories from $100.00 to $130.00 and gave the company an "equal weight" rating in a research report on Tuesday, August 5th. Stifel Nicolaus increased their price objective on Silicon Laboratories from $144.00 to $160.00 and gave the stock a "buy" rating in a research note on Friday, July 18th. Needham & Company LLC reaffirmed a "buy" rating and set a $150.00 target price on shares of Silicon Laboratories in a research note on Wednesday, May 14th. Finally, KeyCorp upped their target price on Silicon Laboratories from $160.00 to $180.00 and gave the company an "overweight" rating in a report on Tuesday, July 8th. Five investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $151.13.

Silicon Laboratories Price Performance

Shares of NASDAQ SLAB opened at $132.22 on Thursday. Silicon Laboratories, Inc. has a one year low of $82.82 and a one year high of $160.00. The business's 50-day moving average price is $136.52 and its two-hundred day moving average price is $126.61. The company has a market capitalization of $4.34 billion, a P/E ratio of -41.06 and a beta of 1.52.

Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The semiconductor company reported $0.11 earnings per share for the quarter, topping analysts' consensus estimates of $0.09 by $0.02. The company had revenue of $192.85 million during the quarter, compared to the consensus estimate of $192.57 million. Silicon Laboratories had a negative return on equity of 7.21% and a negative net margin of 14.88%.The business's quarterly revenue was up 32.6% on a year-over-year basis. During the same period last year, the business earned ($0.56) EPS. Silicon Laboratories has set its Q3 2025 guidance at 0.200-0.400 EPS. On average, equities analysts anticipate that Silicon Laboratories, Inc. will post -0.97 EPS for the current year.

Insider Transactions at Silicon Laboratories

In other Silicon Laboratories news, SVP Brandon Tolany sold 1,800 shares of the business's stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $133.57, for a total value of $240,426.00. Following the completion of the sale, the senior vice president directly owned 62,328 shares of the company's stock, valued at $8,325,150.96. The trade was a 2.81% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders have sold 12,070 shares of company stock valued at $1,703,472 in the last ninety days. 1.60% of the stock is owned by insiders.

Silicon Laboratories Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.

Want to see what other hedge funds are holding SLAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Silicon Laboratories, Inc. (NASDAQ:SLAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.